{"id":800458,"date":"2025-01-14T08:05:39","date_gmt":"2025-01-14T13:05:39","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\/"},"modified":"2025-01-14T08:05:39","modified_gmt":"2025-01-14T13:05:39","slug":"science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\/","title":{"rendered":"Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation"},"content":{"rendered":"

\nSeasoned Strategist and Former Chief Commercial Officer Poised to Accelerate Access and Equity in Clinical Research
\n<\/h2>\n
\n

MORRISVILLE, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) — Science 37<\/u><\/a>, a leader in enhancing patient access to clinical trials, announces the appointment of Tyler Van Horn as Chief Executive Officer. Formerly the company\u2019s Chief Commercial Officer, Van Horn\u2019s appointment follows his pivotal role in driving operational excellence and shaping the company\u2019s strategic direction to better prioritize client success \u2013 initiatives credited with driving growth for the company.<\/p>\n

Since joining Science 37 in 2021, Van Horn has been a chief architect in assembling and empowering a team capable of matching or surpassing the testing standards and data quality of traditional clinical trial sites. By emphasizing the well-being and safety of patients through the delivery of convenient, at-home services, Van Horn sees Science 37 solving the most acute patient enrollment and study conduct pain points facing its clinical research clients.<\/p>\n

\u201cThe future of clinical research lies in enabling therapies to reach their endpoints faster, gaining approval, and ensuring equitable, improved health outcomes for all,\u201d said Van Horn. \u201cAs CEO, I am dedicated to supporting sponsors with our world-class research teams and innovative solutions. Our commitment to expanding patient access remains at the heart of everything we do, especially as we strive to reach underserved populations and drive meaningful change in healthcare.\u201d<\/p>\n

Van Horn\u2019s elevation to CEO positions Science 37 to seamlessly build upon the learning of past successes. It also redoubles the company\u2019s commitment to growth through purposeful innovation and enhanced solution delivery. By prioritizing the patient and study sponsors, Science 37 is leading the way, ushering in a new era of accessibility, diversity, and patient safety in clinical research.<\/p>\n

For more information about Science 37 and its unique approach to clinical research, visit www.science37.com<\/u><\/a>.<\/p>\n

\n About Science 37<\/strong>\n <\/p>\n

Science 37 accelerates clinical research by expanding patient access to trials, leading to faster approvals and better health outcomes. Our Metasite\u2122 and Patient Recruitment solutions enable life sciences companies to reach beyond traditional means of conducting clinical research. To learn more, visit www.science37.com<\/u><\/a>, or email science37@science37.com<\/u><\/a>.<\/p>\n

To view studies that Science 37 is actively recruiting for, please visit https:\/\/studies.science37.com\/current-studies<\/u><\/a>.<\/p>\n

\n Media Inquiries<\/strong>\n <\/p>\n

Science 37
pr@science37.com<\/u><\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Seasoned Strategist and Former Chief Commercial Officer Poised to Accelerate Access and Equity in Clinical Research MORRISVILLE, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) — Science 37, a leader in enhancing patient access to clinical trials, announces the appointment of Tyler Van Horn as Chief Executive Officer. Formerly the company\u2019s Chief Commercial Officer, Van Horn\u2019s appointment follows his pivotal role in driving operational excellence and shaping the company\u2019s strategic direction to better prioritize client success \u2013 initiatives credited with driving growth for the company. Since joining Science 37 in 2021, Van Horn has been a chief architect in assembling and empowering a team capable of matching or surpassing the testing standards and data quality of traditional clinical trial sites. By emphasizing … <\/p>\n

Continue reading “Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-800458","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nScience 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Seasoned Strategist and Former Chief Commercial Officer Poised to Accelerate Access and Equity in Clinical Research MORRISVILLE, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) — Science 37, a leader in enhancing patient access to clinical trials, announces the appointment of Tyler Van Horn as Chief Executive Officer. Formerly the company\u2019s Chief Commercial Officer, Van Horn\u2019s appointment follows his pivotal role in driving operational excellence and shaping the company\u2019s strategic direction to better prioritize client success \u2013 initiatives credited with driving growth for the company. Since joining Science 37 in 2021, Van Horn has been a chief architect in assembling and empowering a team capable of matching or surpassing the testing standards and data quality of traditional clinical trial sites. By emphasizing … Continue reading "Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-14T13:05:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMTY5MSM2NjkyNzI3IzIyMjIwMjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation\",\"datePublished\":\"2025-01-14T13:05:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\\\/\"},\"wordCount\":384,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMzMTY5MSM2NjkyNzI3IzIyMjIwMjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\\\/\",\"name\":\"Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMzMTY5MSM2NjkyNzI3IzIyMjIwMjY=\",\"datePublished\":\"2025-01-14T13:05:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMzMTY5MSM2NjkyNzI3IzIyMjIwMjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMzMTY5MSM2NjkyNzI3IzIyMjIwMjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\/","og_locale":"en_US","og_type":"article","og_title":"Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation - Market Newsdesk","og_description":"Seasoned Strategist and Former Chief Commercial Officer Poised to Accelerate Access and Equity in Clinical Research MORRISVILLE, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) — Science 37, a leader in enhancing patient access to clinical trials, announces the appointment of Tyler Van Horn as Chief Executive Officer. Formerly the company\u2019s Chief Commercial Officer, Van Horn\u2019s appointment follows his pivotal role in driving operational excellence and shaping the company\u2019s strategic direction to better prioritize client success \u2013 initiatives credited with driving growth for the company. Since joining Science 37 in 2021, Van Horn has been a chief architect in assembling and empowering a team capable of matching or surpassing the testing standards and data quality of traditional clinical trial sites. By emphasizing … Continue reading \"Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\/","og_site_name":"Market Newsdesk","article_published_time":"2025-01-14T13:05:39+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMTY5MSM2NjkyNzI3IzIyMjIwMjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation","datePublished":"2025-01-14T13:05:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\/"},"wordCount":384,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMTY5MSM2NjkyNzI3IzIyMjIwMjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\/","name":"Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMTY5MSM2NjkyNzI3IzIyMjIwMjY=","datePublished":"2025-01-14T13:05:39+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMTY5MSM2NjkyNzI3IzIyMjIwMjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMTY5MSM2NjkyNzI3IzIyMjIwMjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/science-37-appoints-tyler-van-horn-as-ceo-to-lead-next-era-of-patient-access-innovation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/800458","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=800458"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/800458\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=800458"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=800458"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=800458"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}